Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Vaginal Dilator Use on Vaginal Morbidity and Quality of Life Following Definitive Radiation Therapy for Cervical Cancer.

NCT07698795 is registered in ClinicalTrials.gov with Chulabhorn Cancer Center as lead sponsor.

NCT NCT07698795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Vaginal Dilator Use on Vaginal Morbidity and Quality of Life Following Definitive Radiation Therapy for Cervical Cancer.
Lead sponsor
Chulabhorn Cancer Center
Phase
Observational
Overall status
Completed
Start date
April 3, 2020
Completion date
April 30, 2022
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer radiation complications, qol